Mylan Venlafaxine Xl 75 mg, 150 mg Capsule
PDF Leaflet Revision Date: 18 December 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of depression and prevention of relapse.
Dosage (summary)
75 mg once daily, may increase to 150 mg or 225 mg if needed.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Not established; avoid breastfeeding.
Key Drug Interactions
- MAOIs
- Alcohol
- Warfarin
Contraindications
- Hypersensitivity
- Children under 18
- Concomitant MAOIs
Common side effects
- Nausea
- Dizziness
- Insomnia
- Dry mouth
Counselling Points
- Take with food
- Do not crush or chew capsules
- Monitor for worsening depression
Serious warnings
- Risk of serotonin syndrome
- Suicidal thoughts
- Hypertension
Important Disclaimer
The Mylan Venlafaxine Xl 75 mg, 150 mg Capsule professional information leaflet below is the property of Viatris South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
